Generics

Fosapreptant for injection had a market value of over $350 million for 2018, according to IQVIA.

Kadmon has received the FDA's approval for a generic of Bausch Health's Syprine capsules.

The Association for Accessible Medicines released a white paper highlighting new data on the treatment of generic medicines in Medicare Part D.

The generic is indicated to treat acute, uncomplicated influenza A and B in patients 2 weeks of age and older who have been symptomatic for less than 48 hours.

Edecrin tablets had a market value of approximately $24 million, according to IQVIA June 2019 data.

Hikma's heparin sodium injection prefilled syringes are ready-to-administer to help treat patients faster and with reduced risk, the company said.

Fulvestrant injection, 250 mg/5 mL (50 mg/mL) per single-dose prefilled syringe, had a market value of approximately $550 million for the 12 months ended June 30.